コンテンツへスキップ
Merck

Rat atrial responses to Bothrops jararacussu (jararacuçu) snake venom.

Toxicology (2014-06-29)
Mariana A P Rodrigues, Lourdes Dias, André L Rennó, Norma C Sousa, Adriana Smaal, Delano A da Silva, Stephen Hyslop
要旨

Envenoming by the pitviper Bothrops jararacussu produces cardiovascular alterations, including coagulopathy, systemic hemorrhage, hypotension, circulatory shock and renal failure. In this work, we examined the activity of this venom in rat isolated right atria. Incubation with venom (0.025, 0.05, 0.1 and 0.2mg/ml) caused concentration-dependent muscle contracture that was not reversed by washing. Muscle damage was seen histologically and confirmed by quantification of creatine kinase-MB (CK-MB) release. Heating and preincubation of venom with p-bromophenacyl bromide (a phospholipase A2 inhibitor) abolished the venom-induced contracture and muscle damage. In contrast, indomethacin, a non-selective inhibitor of cyclooxygenase, and verapamil, a voltage-gated Ca(2+) channel blocker, did not affect the responses to venom. Preincubation of venom with Bothrops or Bothrops/Crotalus antivenom or the addition of antivenom soon after venom attenuated the venom-induced changes in atrial function and tissue damage. These results indicate that B. jararacussu venom adversely affected rat atrial contractile activity and muscle organization through the action of venom PLA2; these venom-induced alterations were attenuated by antivenom.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
インドメタシン, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
クレアチンホスホキナーゼ ウサギ筋肉由来, Type I, salt-free, lyophilized powder, ≥150 units/mg protein
Sigma-Aldrich
(±)-ベラパミル 塩酸塩, ≥99% (titration), powder
Sigma-Aldrich
2,4′-ジブロモアセトフェノン, >98%
Sigma-Aldrich
クレアチンホスホキナーゼ ウシ心臓由来, Type III, salt-free, lyophilized powder, ≥30 units/mg protein
USP
ベラパミル 塩酸塩, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
インドメタシン, meets USP testing specifications
Supelco
ベラパミル 塩酸塩 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
USP
インドメタシン, United States Pharmacopeia (USP) Reference Standard
Supelco
インドメタシン, Pharmaceutical Secondary Standard; Certified Reference Material
(±)-ベラパミル 塩酸塩, European Pharmacopoeia (EP) Reference Standard
Supelco
(±)-ベラパミル 塩酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
2,4′-ジブロモアセトフェノン, for HPLC derivatization, LiChropur, ≥99.0% (HPLC)
インドメタシン, European Pharmacopoeia (EP) Reference Standard